Video Experimental Relacionado
Updated: Aug 15, 2026
08:04
Overlapping Peptide Library to Map Qa-1 Epitopes in a Protein
Published on: December 20, 2017
La respuesta inmune humana al anticuerpo monoclonal OKT3 es oligoclonal
Science (New York, N.Y.)
|June 13, 1986
Resumen
El anticuerpo monoclonal murino OKT3 se utiliza para la inmunosupresión en el trasplante, pero causa una respuesta de anticuerpo. Esta respuesta es oligoclonal, lo que sugiere que el uso consecutivo de diferentes anticuerpos con la misma especificidad podría superar la sensibilización.
Área de la Ciencia:
- Inmunología Inmunología.
- Medicina del trasplante Medicina del trasplante.
- Biotecnología La biotecnología es la biotecnología.
Sus antecedentes:
- Los anticuerpos monoclonales, como el OKT3, son cruciales para la inmunosupresión en el trasplante clínico.
- OKT3 se dirige a un complejo en linfocitos T humanos maduros, vinculados al receptor de células T.
- El uso terapéutico de anticuerpos monoclonales murinos está limitado por las respuestas de anticuerpos del paciente, lo que reduce la eficacia.
Objetivo del estudio:
- Para investigar la naturaleza de la respuesta de anticuerpos a OKT3.
- Explorar estrategias para superar la sensibilización inmune a los anticuerpos monoclonales in vivo.
Principales métodos:
- Utilizó la técnica del hibridoma para la generación de anticuerpos.
- Empleado isoelectrofocusing para analizar la respuesta del anticuerpo a OKT3.
Principales resultados:
- Se confirmó que la respuesta de anticuerpos a OKT3 estaba restringida en especificidad (antiisotípica y antiidiotípica).
- El isoelectrofocusing reveló que la respuesta del anticuerpo anti-OKT3 es oligoclonal.
- Esta naturaleza oligoclonal sugiere una posible limitación en la amplitud de la respuesta inmune.
Conclusiones:
- La respuesta inmune a OKT3 es oligoclonal, no policlonal.
- La administración consecutiva de anticuerpos monoclonales distintos con especificidad compartida pero con idiotipos diferentes puede eludir la sensibilización.
- Esta estrategia podría prolongar la eficacia terapéutica de la inmunosupresión basada en anticuerpos monoclonales.
Más Videos Relacionados
Videos de Conceptos Relacionados
01:36Humoral Immune Responses
Overview
01:31Hybridoma Technology
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
01:23Cells of the Adaptive Immune Response
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
01:22T Cell Activation and Clonal Selection
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:24B Cell Activation and Differentiation
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...